Sanofi and Translate Bio Initiate Phase 1 Clinical Trial of mRNA Influenza Vaccine
June 22, 2021 01:00 ET
|
Translate Bio, Inc.
-- Trial will evaluate potential of next generation of influenza vaccines with combined mRNA technology and flu vaccine development expertise -- -- Positive preclinical safety and immunogenicity data...
Enochian BioSciences Announces Acquisition of Exclusive License for Potential Pan-Coronavirus and Pan-Influenza Inhaled Treatment and Prevention Technology
June 21, 2021 07:00 ET
|
Enochian BioSciences, Inc.
LOS ANGELES, June 21, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today...
Vaccines Market Size to Reach USD 73.78 Billion in 2028; Increasing government funding for vaccine production and growing emphasis on immunization are major factors expected to drive the market, Says Reports and Data
June 02, 2021 13:43 ET
|
Reports and Data
New York, June 02, 2021 (GLOBE NEWSWIRE) -- Market Size – USD 42 Billion in 2020 Market Growth – 7.3% Market Trends – Expanding pharmaceutical industry and drive to vaccinate all The global...
Vystar Partners with “Nothing in the Air” for RxAir Marketing, Advertising & Distribution
June 02, 2021 08:30 ET
|
Vystar Corp.
NITA president one of nation’s top 100 TV healthcare content producersLaunching ROKU Campaign June 3 Worcester, MA and PALM DESERT, CA, June 02, 2021 (GLOBE NEWSWIRE) -- Vystar® Corporation’s...
Global Antiviral Therapies Market Expected to Surpass to $66,016.5 Million and Exhibit a CAGR of 3.1% from 2020 to 2027 - Exclusive Report [Pages - 208] by Research Dive
April 12, 2021 09:15 ET
|
Research Dive
New York, USA , April 12, 2021 (GLOBE NEWSWIRE) -- Research Dive in its latest published report estimates that the global antiviral therapies market will generate $66,016.5 million and exhibit...
Antiviral Drugs Market Size & Share | North America, Europe, & APAC Industry Forecasts 2027: Graphical Research
April 12, 2021 06:00 ET
|
Graphical Research
Pune, India, April 12, 2021 (GLOBE NEWSWIRE) -- The global antiviral drugs market size is anticipated to witness accelerated growth during the forecast period due to the growing focus toward...
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
February 25, 2021 16:01 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the fourth quarter and full year ended...
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
February 17, 2021 07:04 ET
|
Vir Biotechnology, Inc.
– Companies applying their combined expertise in immunology and infectious diseases to accelerate the development of promising monoclonal antibody candidates for influenza – – Functional genomics...
Aegis Sciences Corporation Launches Combined Test for SARS-CoV-2 and Influenza A/B Virus
November 16, 2020 11:20 ET
|
Aegis Sciences Corporation
NASHVILLE, Tenn., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services...
7 Hills Pharma Announces First Healthy Volunteers Dosed in Landmark Phase 1 Trial of Immunostimulant to Improve Immuno-Oncology Drugs, COVID-19 and Influenza Vaccines
November 09, 2020 05:30 ET
|
7 Hills Pharma
HOUSTON, Nov. 09, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a clinical stage immunotherapy company focused on the development of drugs for treatment and prevention of cancer and infectious diseases,...